Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorbald van Hall

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Iscience|May 4, 2026
A fully human pan VL9 HLA-E TCRm antibody enables functional dissection of HLA-E biology and checkpoint signalingSoroush Ghaffari, Katherine Upchurch-Ange, Gizem Oter, et al.
Cancer Research|July 19, 2005
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoireRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytesMarloes Gooden, Margit Lampen, Ekaterina S Jordanova, et al.
The Journal of Clinical Investigation|January 20, 2016
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumorsElien M Doorduijn, Marjolein Sluijter, Bianca J Querido, et al.
Frontiers in Immunology|February 10, 2018
T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1<sup>b</sup> with TAP-Independent Peptides Are Semi-Invariant LymphocytesElien M Doorduijn, Marjolein Sluijter, Bianca J Querido, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 26, 2011
Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTLAurélie Durgeau, Faten El Hage, Isabelle Vergnon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2018
The Immunogenicity of a Proline-Substituted Altered Peptide Ligand toward the Cancer-Associated TEIPP Neoepitope Trh4 Is Unrelated to Complex StabilityIda Hafstrand, Elien M Doorduijn, Renhua Sun, et al.
Journal for Immunotherapy of Cancer|March 13, 2023
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapyMarit J van Elsas, Camilla Labrie, Anders Etzerodt, et al.
Blood|June 8, 2007
Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantationRoelof Flierman, Geert Westerhuis, Marjolijn Hameetman, et al.
Journal for Immunotherapy of Cancer|October 19, 2019
Monalizumab: inhibiting the novel immune checkpoint NKG2AThorbald van Hall, Pascale André, Amir Horowitz, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Iscience|May 4, 2026
A fully human pan VL9 HLA-E TCRm antibody enables functional dissection of HLA-E biology and checkpoint signalingSoroush Ghaffari, Katherine Upchurch-Ange, Gizem Oter, et al.
Cancer Research|July 19, 2005
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoireRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytesMarloes Gooden, Margit Lampen, Ekaterina S Jordanova, et al.
The Journal of Clinical Investigation|January 20, 2016
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumorsElien M Doorduijn, Marjolein Sluijter, Bianca J Querido, et al.
Frontiers in Immunology|February 10, 2018
T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1<sup>b</sup> with TAP-Independent Peptides Are Semi-Invariant LymphocytesElien M Doorduijn, Marjolein Sluijter, Bianca J Querido, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 26, 2011
Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTLAurélie Durgeau, Faten El Hage, Isabelle Vergnon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2018
The Immunogenicity of a Proline-Substituted Altered Peptide Ligand toward the Cancer-Associated TEIPP Neoepitope Trh4 Is Unrelated to Complex StabilityIda Hafstrand, Elien M Doorduijn, Renhua Sun, et al.
Journal for Immunotherapy of Cancer|March 13, 2023
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapyMarit J van Elsas, Camilla Labrie, Anders Etzerodt, et al.
Blood|June 8, 2007
Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantationRoelof Flierman, Geert Westerhuis, Marjolijn Hameetman, et al.
Journal for Immunotherapy of Cancer|October 19, 2019
Monalizumab: inhibiting the novel immune checkpoint NKG2AThorbald van Hall, Pascale André, Amir Horowitz, et al.
Pageof 13